DRUG

ANTIFUNGAL

DRUG NAME:
GENERIC: Sporanox

BRAND: ITRACONAZOLE

CLASSIFICATION: antifungal

USE: treatment

dermatophyte infection of fingernails or toenails in nonimmunocompromised

pt.

oropharyngeal esephageal candidiasis

ACTION: inhibits enziymes necessary for integrity of the fungal cell

membrane

ADVERSE AND SIDE EFFECTS: CNS DIZZINESS, drowsiness, fatigue, EENT

hearing loss CV CHF, edema, GI hepatoxicity, nausea, abdominal pain,
anorexia, diarrhea, GU albuminuria, decreased libido, DERM toxic epidermal
necrolysis, photosensitivity,puritus, rash, Mis: allergic reaction including
anaphylaxis

Route: po oropharyngeal 200mg daily for 1-2 wks. oropharyngeal

candidiasis 100mg bid for at least 1-2 weeks

Assessment

assess for signs and symptoms of infection (vital signs, lung sounds, sputum,
WBC, oral and pharynageal mucosa,nail beds) before and periodically during
theraphy.

obtain specimens for c&s before theraphy.

Nursing diagnoses

risk for infection

noncompliance-pt. family teaching

Implementation

do not interchange capsules and oral solutions

administer with a full meal to minimize nausea or vomiting and to increase

absorption

do not administer with antacids or other meds. that may increase gastric ph.

Patient teaching

to take med as directed even if feeling better

take at same time each day

INSTRUCT PATIENT TO NOTIFY HEALTH CARE PROFESSIONAL OF SIDE

EFFECTS OR ADVERSE REACTION OR SOB

must consult with health care professional if taking OCT meds

take with meals

to use sunscreen and protective clothing a med photosenitive.

Evaluation

resolution of fungal infection